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High mannose-specific lectin Msl 
mediates key interactions of the 
vaginal Lactobacillus plantarum 
isolate CMPG5300
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Sam Noppen3, Els J. M. Van  Damme4, Sandra Liekens3, Jan Balzarini3, Dominique Schols3, 
Jos Vanderleyden1 & Sarah Lebeer1,2
To characterize the interaction potential of the human vaginal isolate Lactobacillus plantarum 
CMPG5300, its genome was mined for genes encoding lectin-like proteins. cmpg5300.05_29 was 
identified as the gene encoding a putative mannose-binding lectin. Phenotypic analysis of a gene 
knock-out mutant of cmpg5300.05_29 showed that expression of this gene is important for auto-
aggregation, adhesion to the vaginal epithelial cells, biofilm formation and binding to mannosylated 
glycans. Purification of the predicted lectin domain of Cmpg5300.05_29 and characterization of its 
sugar binding capacity confirmed the specificity of the lectin for high- mannose glycans. Therefore, we 
renamed Cmpg5300.05_29 as a mannose-specific lectin (Msl). The purified lectin domain of Msl could 
efficiently bind to HIV-1 glycoprotein gp120 and Candida albicans, and showed an inhibitory activity 
against biofilm formation of uropathogenic Escherichia coli, Staphylococcus aureus and Salmonella 
Typhimurium. Thus, using a combination of molecular lectin characterization and functional assays, 
we could show that lectin-sugar interactions play a key role in host and pathogen interactions of a 
prototype isolate of the vaginal Lactobacillus microbiota.
Given the key importance of the urogenital microbiota for human reproduction, increasing efforts are put in place 
to characterize this microbiome in healthy and pathogenic or unwanted conditions such as bacterial vaginosis 
(BV) and preterm labor1. Compared to microbial communities at other human body sites, the vagina provides 
an interesting case since dominance by specific bacterial taxa - namely Lactobacillus species- is clearly linked to 
a healthy state2. These lactobacilli appear to promote the protection of the urogenital tract from viral pathogen 
invasion such as Human Immunodeficiency Virus (HIV)2,3 and Herpes Simplex virus-2 (HSV-2)4, bacterial and 
yeast pathogens such as Escherichia coli5 and Staphylococcus aureus6 and Candida albicans7, respectively. However, 
the molecular mechanisms behind the health-promoting effects of vaginal lactobacilli are in general not well 
known. One of the postulated health benefits of lactobacilli is based on the direct inhibition of pathogens by the 
production of active compounds such as lactic acid and bacteriocins (Petrova et al.2). Another mechanism by 
which lactobacilli are known to prevent infections is by preventing adhesion, invasion and biofilm formation 
of the pathogens. For example, vaginal lactobacilli have been suggested to be able to prevent and/or treat E. 
coli-associated urinary tract infections (UTI) and aerobic vaginitis8,9, but the molecules involved are not well 
studied. Cell surface molecules of lactobacilli could play a role in pathogen exclusion by (1) competitive binding 
to the same receptors as pathogens on the host surface, thereby blocking pathogen adhesion or (2) by binding to 
ligands on the pathogenic surfaces, thereby blocking virulence mechanisms such as invasion and/or promoting 
enhanced exposure to the secreted antimicrobials of lactobacilli2.
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Lectins are specific sugar-binding proteins or carbohydrate-binding agents (CBAs). Because of the key role 
of sugar recognition in many physiological functions, they can be postulated to mediate crucial functions of the 
human microbiota, including colonization of the host and interaction with pathogens10. Yet, they are underex-
plored in functional microbiota studies. In this study, we investigated the lectin-sugar interaction potential of a 
vaginal microbiome isolate, Lactobacillus plantarum CMPG5300, for which we recently determined the genome 
sequence11. Genome mining of L. plantarum CMPG5300 resulted in the identification of cmpg5300.05_29 as the 
gene encoding a putative mannose-binding lectin.
Results
Identification of the putative lectin-like encoding cmpg5300.05_29 gene on a ~28 kb plasmid. 
When we mined the genome sequence of L. plantarum CMPG5300 for putative lectin-encoding genes (Malik et al.11), 
the sortase-dependent, putative mannose-specific adhesin-encoding gene cmpg5300.05_29 of CMPG5300 was 
found to be located at the start and the end of a contig (contig 54) indicating the contig was circular, hence a 
plasmid. The gene cmpg5300.05_29 shows 72% identity to the mannose specific adhesin (msa) gene lp_1229 
of Lactobacillus plantarum WCFS112 at DNA level, while the encoded proteins show 61% similarity (5e-55). 
However, Cmpg5300.05_29 is 193 amino acids longer than that of L. plantarum WCFS1 (Lp_1229). The protein 
consists of a ConA-like domain, classified as a Legume-L type lectin followed by Type I MUB domain and four 
copies of Type II MUB domains.
Validation of the plasmid location was done experimentally, with PCR and Southern hybridization with var-
ious primers mentioned in Table S1 and probes depicted in Fig. 1a. Since the cmpg5300.05_29 gene itself con-
tains a lot of repetitions, we focused on detecting the regulator encoding gene cmpg5300.05_28 located upstream 
from this sequence. Southern hybridization indeed confirmed the presence of the genes cmpg5300.05_28 and 
cmpg5300.05_29 mainly in the plasmid DNA samples (Fig. 1b and c). The size of the plasmid hybridizing with 
cmpg5300.05_28 also corresponds to the size of contig 54 on which cmpg5300.05_29 is located, which is ~28 kb. 
This plasmid location is unlike the chromosomally-located homologous msa genes in other L. plantarum strains13, 
as confirmed here for L. plantarum strain WCFS1 (Fig. 1b and c).
Figure 1. Plasmid location of cmpg5300.05_29. (a) Schematic illustration of the genetic organization of 
cmpg5300.05_29 on the putative plasmid contig 54. The primer pair PRO 7189 and PRO 7037 (black arrows) 
was used for constructing the probe for Southern hybridization. (b) Southern blot analysis. DNA gel profile for 
CMPG5300- Lane Gene ruler: High range ladder; Lane gDNA: Total genomic DNA preparation (band encircled 
in black); Lane pDNA undigested: Total plasmid DNA preparation-undigested (500 ng/ml); Lane pDNA 
digested: Total plasmid DNA digested with restriction enzymes (500 ng/ml); Lane DIG ladder: DIG ladder. 
DNA gel profile for WCFS1- Lane Gene ruler: High range ladder; Lane gDNA: Total genomic DNA; Lane DIG 
ladder: DIG ladder. (c) Southern blot of CMPG5300- Lane DIG ladder: DIG ladder; Lane pDNA digested: Total 
plasmid DNA digested (500 ng/ml); Lane pDNA undigested: Total plasmid DNA-undigested (500 ng/ml); Lane 
gDNA: Total genomic DNA. Southern blot of WCFS1- Lane gDNA: Total genomic DNA; Lane DIG ladder: DIG 
ladder. Southern hybridization of a 487-bp cmpg5300.05_28-specific labeled fragment gave a binding signal (at 
a size slightly higher than 21.2 kbp) marked in black solid arrow (in both DNA gel and Southern blot pictures) 
with the plasmid DNA preparations indicating the plasmid location of cmpg5300.05_29. No signal was obtained 
at the position of the total DNA (encircled). On the other hand, the 772-bp labeled fragment of L. plantarum 
WCFS1 (used as control) yielded a signal corresponding to band of the chromosomal DNA preparation.
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Mutant analysis shows a key role for Cmpg5300.05_29 in auto-aggregation and adhesion. 
Subsequently, the cmpg5300.05_29 knock-out mutant designated CMPG11201 was constructed by double 
homologous recombination. This mutant strain CMPG11201 did not display extensive cell clumping, as observed 
for the wild-type CMPG5300 (Fig. 2a and b). In contrast, the complemented strain CMPG11202 exhibited cell 
clumps, nonetheless smaller than the wild-type L. plantarum CMPG5300, suggesting that the phenotype was not 
fully restored (Fig. 2c). Of note, the mutant showed the same growth characteristics as wild-type strain L. plan-
tarum CMPG5300 when grown in MRS (Fig. 2d). L. plantarum CMPG5300 and mutant CMPG11201 were then 
analyzed for adhesion to the vaginal epithelial cell line VK2/E6E7 (Fig. 2e) and biofilm formation (Fig. 2f) on a 
polystyrene surface. A significant decrease of ~80 percent was observed for adhesion and ~50 percent for biofilm 
formation in case of the mutant strain CMPG11201 compared to the wild-type. The restoration of the phenotype 
of the complemented strain CMPG11202 substantiates the role of this lectin in the adhesive and biofilm-forming 
Figure 2. Phenotypic analysis of the mutant strain CMPG11201. (a) Overnight cultures of L. plantarum 
CMPG5300 (b) its mutant CMPG11201, and (c) complemented strain CMPG11202 in MRS medium. Phase-
contrast microscopic images show extensive cell clumps in the case of L. plantarum CMPG5300 (a) and 
some clumps in the complemented strain CMPG11202 (c), in contrast to the small-sized clusters and mostly 
single cells that are seen with the mutant CMPG11201 (b). (d) Growth capacity of L. plantarum CMPG5300, 
CMPG11201 and CMPG11202 mutants in MRS medium. (e) Adhesion capacities of L. plantarum CMPG5300 
and CMPG11201 mutant to VK2/E6E7 vaginal epithelial cells. (f) Biofilm formation capacities of L. plantarum 
CMPG5300 and mutant CMPG11201. The results are expressed relative to the biofilm thickness of L. plantarum 
CMPG5300 wild-type (positive control), which was set at 100%. The error bars represent standard deviations of 
8 biological repeats. The dataset comparisons (mutant pairwise to wild-type or complemented strain pairwise 
mutant strain) are considered significant (p < 0.05 indicated with one asterisks, p < 0.01 indicated with two 
asterisks and p < 0.001 indicated with three asterisks in the figure). (g) Binding of the FITC-labelled lectin 
domain of Msl to VK2/E6E7.
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phenotype of the strain (Fig. 2e and f). Of note, the adhesive capacity of the complemented strain was not fully 
restored to the wild-type level like the biofilm-forming phenotype although it was significantly higher than that 
of the mutant. To validate the role of Msl in the adhesion capacity of the L. plantarum CMPG5300, the FITC- 
labelled lectin domain of Msl was examined for binding to VK2/E6E7 using fluorescence microscopy. The results 
show clear binding of the lectin domain of Msl to VK2/E6E7 epithelial cells (Fig. 2g).
Saccharomyces cerevisiae and Candida albicans agglutination assay shows mannan-binding 
capacity of Cmpg5300.05_29. To obtain a first indication of the sugar specificity of Cmpg5300.05_29, a 
S. cerevisiae BY4741 agglutination assay was performed, which is a standard assay to explore mannose-binding 
activity of bacterial lectins14. L. plantarum CMPG5300 showed a clear capacity to agglutinate S. cerevisiae, which 
was independent of the presence of calcium and magnesium ions (data not shown) and this was reduced sig-
nificantly by addition of methyl-α -D-mannopyranoside (Fig. 3a). In contrast, mutant CMPG11201 showed 
a significant decrease in agglutination (Fig. 3a), while the complemented strain CMPG11202 was also able to 
agglutinate S. cerevisiae to some extent (Fig. 3a). We could corroborate these findings using ELISA where we 
obtained a significant binding of the wild-type strain CMPG5300 to mannan but a clear loss of binding for the 
cmpg5300.05_29 mutant (Fig. 3b). To exclude that other cell surface ligands could still interfere with the results in 
the assay with the mutant strain, we subsequently expressed and purified the lectin domain of Cmpg5300.05_29. 
Only the predicted lectin domain was expressed in E. coli, as we were unable to express the large-sized pro-
tein (encoded by a ~3.6 kb long gene). The purified lectin domain could also agglutinate S. cerevisiae (Fig. 3c) 
and the related yeast pathogen C. albicans (Fig. 3d), as shown after FITC labeling, providing an indication for 
the potential interaction of the lectin with pathogens. This agglutination was significantly reduced in the pres-
ence of methyl-α -D-mannopyranoside (Fig. 3c and d). The L-type lectin domain of lectin-like protein 2 (Llp2) 
isolated from Lactobacillus rhamnosus GG used as a control did not agglutinate S. cerevisiae and C. albicans  
(Fig. 3c and d).
Cmpg5300.05_29 shows specificity for high-mannose N-glycans. To determine the sugar spec-
ificity of Cmpg5300.05_29 in a more precise manner, pull-down sugar-binding assays were performed using 
Sepharose beads coated with various sugar substrates. The well documented mannose-specific Hippeastrum 
hybrid (amaryllis) lectin (HHA)15 was used as a positive control. These experiments showed that the lectin 
domain of Cmpg5300.05_29 binds more strongly to beads coated with mannan compared to uncoated beads and 
beads coated with mannose, glucose, fucose or GlcNAc (Fig. 3e).
The glycan array analysis revealed that the lectin domain binds to especially high mannose N-type glycans 
(Fig. 4a and b, Table S2). These include Manα 1-2Manα 1-6(Manα 1-3)Manα 1-6(Manα 1-2Manα 1-2Manα 
1-3)Manβ 1-4GlcNAcβ 1-4GlcNAcβ -Sp12; Manα 1-6(Manα 1-3)Manα 1-6(Manα 1-3)Manβ 1-4GlcNAcβ 
1-4GlcNAcβ -Sp12; Manα 1-2Manα 1-6(Manα 1-2Manα 1-3)Manα 1-6(Manα 1-2Manα 1-2Manα 1-3)Manα -Sp9 
and Manα 1-6(Manα 1-3)Manα 1-6(Manα 1-2Manα 1-3)Manβ 1-4GlcNAcβ 1-4GlcNAcβ -Sp12.
Interaction between Cmpg5300.05_29 and HIV-1 glycoproteins. Since the HIV-1 glycoproteins 
are enriched in high-mannose N-type glycans16, we determined the interaction of L. plantarum CMPG5300 and 
the lectin domain of Cmpg5300.05_29 with HIV. First, the capacity of CMPG5300 and its mutant derivatives 
to bind to immobilized HIV-1 gp120 and gp41 was analyzed using an ELISA-based approach. The wild-type 
strain L. plantarum CMPG5300 showed a significant and specific binding to both gp120 and gp41 (Fig. 5a and 
b). Whereas, the mutant CMPG11201 did not show any binding, suggesting that Cmpg5300.05_29 imparts the 
gp120 and gp41 binding phenotype to L. plantarum CMPG5300. However, the binding to these sugars could not 
be restored in the complemented strain CMPG11202. Subsequently, we confirmed binding of the lectin domain 
to HIV-1 gp120 with Surface Plasmon Resonance (SPR) (Fig. 5c). This was reversed by 1 mM manα (1-3)manα 
(1-6)man (dotted lines, Fig. 5b), indicating that this trimannose is a competitive inhibitor for binding of the lectin 
domain to the HIV glycoproteins, and that the lectin domain shows affinity for the α (1-3)/α (1-6) configuration of 
mannose. The kinetic results show affinities (KD) in the lower micromolar range (comparable for both gp120 and 
gp41) (Fig. 5d). Comparison of the binding affinities of the lectin domains of L. plantarum CMPG5300 (1.85E-06 
M) and L. plantarum WCFS1 (6.26E-06 M) (Table 1) indicates that the lectin domain of L. plantarum CMPG5300 
shows a higher affinity to both HIV-1 gp120 and gp41, than that of L. plantarum WCFS1, which is not a vaginal 
isolate. However, HHA (used as a positive control) shows a 1,000-fold higher affinity (or 1,000-fold lower KD) 
(1.32E-09 M) for the viral envelope glycoproteins.
Given the binding capacity of the lectin domain to HIV-1 gp120 (and gp41) observed in the SPR experiments, 
it was of interest to determine its capacity to inhibit HIV-1 infection in cell culture. However, addition of the puri-
fied lectin domain even up to a concentration of 200 μ g/ml was not sufficient to measurably inhibit HIV-1 infec-
tion in human CD4+ T-lymphocytic C8166 cell and Raji DCSIGN cultures under our experimental conditions 
where HHA and GRFT were clearly inhibitory at concentrations less than 1 μ g/ml (data not shown).
Anti-biofilm activity of the lectin domain of Cmpg5300.05_29 against common urogenital 
bacterial pathogens. We subsequently focused on the potential of Cmpg5300.05_29 for preventing bac-
terial infections by investigating its role in inhibiting bacterial biofilms. When the purified lectin domain of 
Cmpg5300.05_29 was added to biofilm cultures of uropathogenic Escherichia coli UTI89 at the onset of bio-
film development (t = 0 h), it significantly inhibited biofilm formation of the pathogen by 80 to 90 percent at 
50 μ g/ml and 200 μ g/ml, respectively (Fig. 6a). When added after 1.5 h or 24 h of biofilm development, it could 
reduce biofilm formation up to 60 percent compared to the control, indicating that it could also interfere with 
the later steps of biofilm formation (Fig. 6a). To corroborate the specific activity of Cmpg5300.05_29, ConA and 
HHA, well-known mannose-specific plant lectins, were also investigated for their activity against E. coli UTI89 
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biofilms but no inhibition was observed (Fig. 1Sa). In addition, since E. coli UTI89 biofilm formation is based 
on mannose-specific binding of FimH fimbria, we used D-mannose as a competitive inhibitor in the assay and 
Figure 3. Agglutination assay of L. plantarum CMPG5300, its mutant derivatives and the lectin domain of 
Cmpg5300.05_29 with S. cerevisiae and C. albicans. (a) Phase contrast images of the agglutination assay of S. 
cerevisiae BY4741 (Sc) incubated with L. plantarum CMPG5300, CMPG11201 mutant and CMPG11202 mutant 
alone and in the presence of methyl-α -D-mannopyranoside inhibitor. For each strain and condition tested, 
the experiment was performed at least three times. The images shown are representative of at least five imaging 
fields. (b) Binding of biotin-labeled cells of the wild-type strain L. plantarum CMPG5300, mutant CMPG11201 
and complemented strain CMPG11202 to yeast mannan. The OD at 405 nm reflects the binding efficiency of 
the bacterial strains. BSA was used as a negative control. The dataset comparisons (mutant pairwise to wild-
type) are considered significant (p < 0.01 indicated with two asterisks in the figure). The dataset comparison 
(complemented mutant pairwise to the mutant strain) show no significant differences. (c) Fluorescent images of 
the agglutination assay of S. cerevisiae BY4741 (Sc) and (d) C. albicans SC5314 (Ca) in the presence of the FITC 
labeled lectin domain of Cmpg5300.05_29, FITC labeled lectin domain of Cmpg5300.05_29 in the presence 
of methyl-α -D-mannopyranoside and lectin-like protein 2 (Llp2) from L. rhamnosus GG used as control. For 
each strain and condition tested, the experiment was performed at least three times. The images shown are 
representative of at least five imaging fields. (e) Proteins that bound to uncoated sepharose beads (lane 1, used as 
negative control), sepharose beads coated with various sugars: mannan (lane 2), mannose (lane 3), glucose (lane 
4), fucose (lane 5), GlcNAc (lane 6) as separated by SDS-PAGE. The first six lanes (LD of CMPG5300.05_29) 
represent the lectin domain of CMPG5300.05_29 and the next six lanes represent HHA (used as control).
www.nature.com/scientificreports/
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again, no inhibition of biofilm formation was observed (Fig. 1Sa). Of note, we could not find any effect of the 
lectin on the planktonic growth of E. coli UTI89 under the same growth conditions as during the biofilm forma-
tion (Fig. 6b), indicating that the inhibition is biofilm-dependent. To explore how the lectin domain structurally 
interferes with E. coli UTI89 biofilm formation, microscopic analyses of the biofilms incubated with the lectin 
were performed. The results show that addition of FITC-labeled lectin domain of Cmpg5300.05_29 at the onset 
of the biofilm at concentration 50 μ g/ml led to the formation of large holes in the biofilm (Fig. 6d), as compared 
to the negative control where dense biofilms were seen (Fig. 6c). The lectin domain of Cmpg5300.05_29 was also 
dispersed within the biofilm (Fig. 6d).
The lectin domain of Cmgp5300.05_29 subsequently showed the capacity to inhibit biofilm formation by 
Staphylococcus aureus, a pathogen causing the fatal toxic shock syndrome, with an average biofilm reduction up to 
36 percent in the case of S. aureus strain SH1000 and 41 percent in the case of S. aureus Rosenbach when added at 
the onset of the biofilm (t = 0 h) (Fig. 6e). However, when it was added after 1.5 h or 24 h of biofilm development, 
Figure 4. Glycan array analysis. (a) Binding capacity of 200 μ g/ml of the lectin domain of Msl to high-
mannose glycans. (b) Binding capacity of 20 μ g/ml of the lectin domain of Msl to high-mannose glycans as 
depicted with black arrows in the figure (the structure of the glycans printed on the array can be find on the 
webpage of the CFG, www.functionalglycomics.org) and in Table S2.
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Figure 5. HIV-1 gp120 and gp41 binding of bacterial cells and the purified lectin domain of 
Cmpg5300.05_29. (a) Binding of biotin-labeled cells of the wild-type strain L. plantarum CMPG5300, mutant 
CMPG11201 and complemented strain CMPG11202 to HIV-1 gp120. The OD at 405 nm reflects the binding 
efficiency of the bacterial strains. BSA was used as a negative control. (b) Binding of biotin-labeled cells of the 
wild-type strain L. plantarum CMPG5300, mutant CMPG11201 and complemented strain CMPG11202 to 
HIV-1 gp41. The OD at 405 nm reflects the binding efficiency of the bacterial strains. BSA was used as a negative 
control. (c) Binding of the lectin domain of CMPG5300 (Ld CMPG5300) to HIV-1 gp120 (solid lines) and 
www.nature.com/scientificreports/
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there was no significant anti-biofilm activity, indicating that for these pathogens the inhibition of biofilm for-
mation is merely at the initial stage of adhesion. Bioscreen results showed no effect of the lectin domain on the 
planktonic growth of either strain (Fig. 6f).
Anti-biofilm activity of the lectin domain of Cmpg5300.05_29 against non-urogenital pathogens. 
As for urogenital pathogens, various biofilm assays were also performed with the gastrointestinal pathogen 
Salmonella Typhimurium ATCC14028 and the opportunistic pathogen Pseudomonas aeruginosa. When the puri-
fied domain was added at a concentration of 50 and 200 μ g/ml at the start of the static peg biofilm assay (t = 0 h), 
it led to a significant reduction in biofilm formation by an average of 78 percent (Fig. 7a) for S. Typhimurium, but 
not for P. aeruginosa PA14 (Fig. S1 b). No effect was seen when it was added in the later phases of biofilm devel-
opment (Fig. 7a). Figure 7b demonstrates that even the planktonic growth was not impaired by the lectin domain 
of Cmpg5300.05_29. Similar to the assay of E. coli UTI89, the effect of ConA, HHA, and D-mannose (used as 
controls) against Salmonella Typhimurium ATCC14028 biofilms was also investigated where no inhibition was 
observed (Fig. 1Sa).
Furthermore, microscopic analyses of S. Typhimurium biofilms showed that the addition of FITC-labeled 
lectin domain of Cmpg5300.05_29 at the onset of the biofilm also resulted in the formation of large holes in the 
biofilm with the lectin domain of Cmpg5300.05_29 dispersed within the biofilm (Fig. 7c and d).
Discussion
In this study, we genetically and biochemically identified and characterized a 127 kDa mannose-specific lectin 
Msl from a vaginal Lactobacillus isolate. The lectin was shown to mediate vaginal niche-related functions for 
L. plantarum CMPG5300 including adhesion to vaginal epithelial cells and auto-aggregation. In addition, the 
lectin domain showed the ability of structurally inhibiting biofilm formation by various pathogens, as well as a 
unique interacting capacity with yeast pathogens and viral envelope glycoproteins.
Combining mutant bacterial strains, purified proteins and lectin assays, we could clearly substantiate the 
high-mannose specificity of Msl. Inhibition of yeast agglutination with methyl-mannopyranoside, loss of 
mannan-binding capacity observed for the msl mutant, binding of the purified lectin domain to mannose-coated 
Sepharose beads, binding signal obtained with high-mannose N-glycans in the glycan array and competitive 
inhibition of HIV-1 gp120-binding by a trimer of mannose, all validate the specificity of our L. plantarum lec-
tin to (oligo)mannoses. The fact that the lectin domain is even able to agglutinate yeast cells suggests that each 
lectin domain may bind to several ligands which can be also be predicted from its sequence to form dimmers/
tetramers. This study reports on the detailed and unambiguous characterization of a lectin from a human vaginal 
Lactobacillus member with detailed glycan array studies showing clear sugar-binding activities. Glycan arrays 
have been implemented for the determination of the sugar specificity for only a limited number of putative bac-
terial lectins. For example, the soluble lectin from P. aeruginosa LecB (known as PA-IIL) has been shown to 
bind strongly to a large variety of fucosylated oligosaccharides, such as α -Fuc 1-2 Gal and β -Gal 1-4 α (Fuc1-3)
GlcNAc17. The FimH adhesin located at the tip of type 1 pili of the uropathogenic E. coli (UPEC) play a role in 
attachment to urothelium by binding to mannosylated glycoreceptors18. Furthermore, to the best of our knowl-
edge, only one other L-type bacterial lectin, known as SraP, has been characterized19. SraP isolated from S. aureus 
was shown to have a high specificity for N-acetylneuraminic acid, as determined by SPR analyses, but not by gly-
can array, and appears to play an important role in the adhesion of the strain to human respiratory epithelial cells.
HIV-1 gp120 HIV-1 gp41
ka (1/Ms) kd (1/s) KD (M) ka (1/Ms) kd (1/s) KD (M)
HHA 1.66E + 06 2.19E − 03 1.32E − 09 2.75E + 06 2.29E − 03 8.36E − 10
Lectin domain of Msa 2.62E + 03 1.64E − 02 6.26E − 06 7.15E + 03 2.36E − 02 3.30E − 06
Lectin domain of Msl 3.05E + 04 5.64E − 02 1.85E − 06 2.29E + 04 2.88E − 02 1.62E − 06
Table 1.  Kinetic data for the interaction of the lectin domain of L. plantarum CMPG5300 with HIV-1 
gp120 and gp41. ka: association rate constant, kd: dissociation rate constant and KD: the binding affinity values.
HIV-1 gp41 (solid lines) in terms of Resonance units as analyzed via SPR. The purified lectin domain of Msa of 
L. plantarum WCFS1 (Ld WCFS1) was used as control (solid lines) and HHA was used as positive control (solid 
lines). Upon addition of competitor trimannose Manα (1-3)Manα (1-6)Man to the lectin domains, binding to 
HIV-1 gp120 was abolished (dotted lines). The concentrations of the lectins used are 20 nM, 4 μ M and 1 μ M for 
HHA (left), lectin domain of Msa of L. plantarum WCFS1 (centre) and lectin domain of CMPG5300.05_29 of 
CMPG5300 (right), respectively. A concentration of 1 mM was used for trimannose. (d) Kinetic analysis for the 
interaction of the lectin domain of CMPG5300.05_29 with HIV-1 gp120 and gp41 using the lectin domain of 
Msa and HHA as control. Serial two-fold analyte dilutions (covering a concentration range from 0 to 20 nM for 
HHA, 0 to 4000 nm for Ld WCFS1 and from 0 to 1000 nM for Ld CMPG5300) were injected over the surface 
of the immobilized gp120 and gp41. A 1:1 binding model was applied to determine the kinetic parameters. 
The biosensor chip density was 115 RUs for gp120 and 45 RUs for gp41. The dataset comparisons (mutant 
pairwise to wild-type) are considered significant (p < 0.05 indicated with one asterisks). The dataset comparison 
(complemented mutant pairwise to the mutant strain) show no significant differences.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:37339 | DOI: 10.1038/srep37339
Intriguingly, the lectin-encoding msl gene, as determined by Southern blot hybridization, was found to be 
encoded by one of the plasmids of L. plantarum CMPG5300. To our knowledge, plasmid-encoded adhesins 
have so far not often been reported in lactobacilli except for a study on the probiotic intestinal strain L. para-
casei NFBC338 which encodes for a collagen-binding protein (CD00222) on one of its plasmids20. In contrast, 
plasmid-encoded adhesins and virulence factors that are well-characterized are found especially in enteropath-
ogenic strains such as Yersinia and Salmonella21. The plasmid location of the msl gene could suggest that it is a 
recently acquired property of L. plantarum CMPG5300 through horizontal gene transfer. This transfer might have 
promoted the adaptation of strain CMPG5300 to the vaginal niche, as reflected by our functional assays.
The first niche-related function identified for Msl is its capacity to promote self-aggregation of L. plantarum 
CMPG5300. Self-aggregation is postulated to increase the colonization potential of lactobacilli in environments 
with short residence times22. Auto-aggregation has been documented before for other vaginal Lactobacillus 
strains4,23 but without details on the molecules involved. We previously observed a loss of auto-aggregation in 
the sortase A (srtA) mutant24. The fact that the msl mutant of L. plantarum CMPG5300 is also clearly impaired 
in auto-aggregation now shows a role for the sortase-dependent Msl lectin in the auto-aggregation of this strain. 
Furthermore, we could substantiate a role for the Msl sortase-dependent protein (SDP) in adhesion of this bac-
terium to the vaginal VK2/E6E7 cell line. This is in agreement with our previous observations that showed a 
significant decrease in adhesion of the sortase mutant to the VK2/E6E7 cell line24. Even though this phenotype 
was restored in the complemented strain, the auto-aggregating and the adhesive capacities were observed to be 
reduced when compared with the wild-type. This is in accordance with the results of the complemented srtA strain 
CMPG5378 (Malik et al.24) where the phenotype could not be restored to the wild type level. This could partly 
be due to the copy number effect where the copy number of Cmpg5300.05_29 on the endogenous plasmid of 
CMPG5300 is different than the one on CMPG11202. Former work on the adhesive factors of vaginal Lactobacillus 
strains has indicated the involvement of glycoproteins in Lactobacillus acidophilus and Lactobacillus gasseri, 
carbohydrates in Lactobacillus jensenii25 and a non-secretory substance in Lactobacillus crispatus CTV-0526. 
However, it remains to be determined whether a related lectin mediates the adhesion in these other vaginal strains 
as well. For the strain L. plantarum CMPG5300, further functional characterization of the msl mutant also sub-
stantiates a role for the Msl lectin in biofilm formation. This phenotype is probably directly linked to the role of 
Msl in auto-aggregation as a first step in biofilm formation.
High-mannose N-type glycans are found on the glycoproteins of HIV-1 especially on its glycoprotein gp12027. 
The use of CBAs is thus currently explored as a novel microbicidal strategy to prevent HIV infection in the 
vagina28. We observed that Msl has the capacity to interact with the high-mannose envelope glycoprotein of the 
pathogen HIV. While wild-type L. plantarum CMPG5300 clearly bound to the HIV glycoprotein gp120 (based on 
ELISA), the msl mutant significantly lost this binding capacity. In addition, the purified lectin domain exhibited 
a strong gp120 binding capacity, as determined by SPR analyses, which could be blocked in the presence of an 
oligomer of mannose. Of note, the mannosylation of gp120 closely resembles the glycans to which Msl shows 
the strongest binding (Manα 1-2Manα 1-6(Manα 1-3)Manα 1-6(Manα 1-2Manα 1-2Manα 1-3)Manβ 1-4GlcNAcβ 
1-4GlcNAcβ -Sp12). Some mannose-binding plant lectins are known to have anti-HIV activity by virtue of their 
specific binding to the highly mannosylated glycoprotein gp12027. Moreover, mannose-binding lectin (MBL) 
detected in vaginal secretions of women was found to be antimicrobial in nature and its deficiency is associ-
ated with the recurrence of infections by C. albicans29. The present study characterizes an HIV-1 gp120 bind-
ing lectin from a Lactobacillus strain. However, we were not able to observe anti-HIV-1 activity in vitro in the 
standard cellular assays at the tested concentrations (up to 200 μ g/ml) of the lectin domain. This may indicate 
that the Msl lectin domain binds to gp120 in a non-neutralizing manner like some antibodies, as documented 
previously30. Alternatively, the lectin may be quickly inactivated in the cell culture due to the presence of proteases 
in the bovine serum-containing medium or to the presence of serum sugars that bind (neutralize) the bacterial 
lectin. Since the Msl lectin is normally presented on live L. plantarum CMPG5300 cells and this configuration is 
probably important in vivo for pathogen interaction of these lactobacilli in the vaginal niche, we believe that the 
lack of efficacy observed in these in vitro assays should not exclude further exploration of the trapping of HIV by 
lectins/live lactobacilli. Such trapping could eventually eliminate the virus from the vaginal environment by the 
vaginal fluid in vivo since lectin-mediated binding of vaginal lactobacilli to pathogens could expose the latter to 
the antimicrobial compounds secreted by lactobacilli, including lactic acid. However, experimental substantiation 
of such in vivo activity for specific lectins and lactobacilli is severely hampered by the difficulty of animal models 
for HIV31, although some progress is being made32.
Since it can be envisaged that it is more difficult to inhibit invasion of small viral particles compared to larger 
bacteria, we subsequently focused on the possible role of Cmpg5300.05_29 in preventing bacterial infections 
by investigating its role in inhibiting bacterial biofilms. Recurrent biofilms are a major problem in urogenital 
infections33. Our results show that the lectin domain of Msl has a remarkable capacity to prevent UPEC and S. 
Typhimurium biofilm formation, as well as moderately affect biofilms of S. aureus strains. Previous studies have 
reported the ability of probiotic lactobacilli to interfere with pathogenic biofilms34–36, but without identifying 
the underlying mode of action. Our findings show the inhibitory capacity of a bacterial, and more specifically a 
Lactobacillus lectin, against bacterial pathogens. The localization of Msl within pathogenic biofilms as observed 
after FITC-labeling suggests that the lectin interacts with components of the biofilm matrix, composed of extra-
cellular polymeric substances, including polysaccharides, proteins such as fimbriae and lectins, DNA and lipids37 
and interferes with stabilization of the biofilm. The composition of the biofilm matrix varies among strains, which 
may also explain the observed species-specific activity of the lectin against various species. For example, both S. 
Typhimurium and E. coli biofilm matrices contain the polysaccharides cellulose (β -1, 4-D-glucose polymer) and 
colanic acid (heteropolysaccharide of glucose, galactose, fucose and glucuronic acid)38,39, which can be a target for 
Msl. The substantiation of biofilm-inhibiting effect using in vivo studies including competitive exclusion is worth 
further exploration, given the prevalence of problems associated with biofilms and the increased resistance of 
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Figure 6. Activity of the lectin domain of Cmpg5300.05_29 against E. coli UTI89, S. aureus SH1000 and 
Rosenbach. (a) Anti-biofilm activity of the lectin domain of Cmpg5300.05_29 against E. coli UTI89 expressed 
as percentage inhibition of biofilm formation. The purified lectin domain of Cmpg5300.05_29 was added after 
0, 1.5 and 24 h to the biofilms at a concentration of 50 μ g/ml and 200 μ g/ml. (b) Growth of E. coli UTI89 in 
TSB in the presence of lectin domain of Cmpg5300.05_29 added at 50 μ g/ml and 200 μ g/ml. (c) Microscopic 
images of E. coli UTI89 biofilms grown only in 1/20 TSB and (d) with 50 μ g/ml of FITC-labeled lectin domain of 
Cmpg5300.05_29. Holes in the biofilms are indicated with arrows. (e) Anti-biofilm activity of the lectin domain 
of Cmpg5300.05_29 against S. aureus SH1000 and Rosenbach. The purified lectin domain of Cmpg5300.05_29 
was added after 0, 1.5 and 24 h to the biofilms at concentration of 50 μ g/ml and 200 μ g/ml. (f) Growth of S. 
aureus SH1000 and Rosenbach in TSB in presence of lectin domain of Cmpg5300.05_29 added at 50 μ g/ml 
and 200 μ g/ml. The dataset comparisons (biofilm formation with addition of lectin to biofilm without adding 
lectins) are considered significant (p < 0.05 indicated with one asterisks, p < 0.01 indicated with two asterisks 
and p < 0.001 indicated with three asterisks in the figure).
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various bacteria against antibiotics40. The Msl lectin, by itself or when present on live lactobacilli, could then have 
a promising potential for local application for exclusion of high-mannose containing pathogens.
This study is thus of relevance for the use of whole bacterial cells as prophylactic probiotics, since the lec-
tins promote the potential colonization capacity of the strains in the human vagina. The enhanced colonization 
of these probiotics could in turn prevent adhesion and colonization by pathogens causing vaginal infections. 
Alternatively, the isolated lectin could be used in therapeutic mode for urogenital as well as gastrointestinal infec-
tions, for instance, in synergy with antibiotics to disrupt biofilms that are otherwise difficult to treat only with 
antibiotics.
Material and Methods
Bacterial strains and culture conditions. L. plantarum CMPG5300 and its mutant derivatives (Table 2) 
were routinely grown without agitation in Man Rogosa Sharpe (MRS) (Difco) at 37 °C. For cloning purpose, 
E. coli TOP10 and BL21/DE3 were grown with shaking at 37 °C in Luria Bertani (LB) medium. When required, 
antibiotics were added at the following final concentrations: chloramphenicol, 20 μ g/ml for L. plantarum and 
10 μg/ml for E. coli; erythromycin, 10 μ g/ml for L. plantarum and 250 μ g/ml for E. coli; ampicillin 100 μ g/ml for E. 
coli and kanamycin 50 μ g/ml for E. coli.
Figure 7. Activity of the lectin domain of Cmpg5300.05_29 against S. Typhimurium ATCC14028.  
(a) Anti-biofilm activity of the lectin domain of Cmpg5300.05_29. The purified lectin domain of 
Cmpg5300.05_29 was added after 0, 1.5 and 24 h to the biofilms at 50 μ g/ml and 200 μ g/ml. (b) Growth of S. 
Typhimurium ATCC14028 in presence of lectin domain of Cmpg5300.05_29 added at 50 μ g/ml and 200 μ g/ml.  
The dataset comparisons (biofilm formation with addition of lectin to biofilm without adding lectins) are 
considered significant (p < 0.05 indicated with one asterisks, p < 0.01 indicated with two asterisks and p < 0.001 
indicated with three asterisks in the figure). (c) Biofilms of S. Typhimurium ATCC14028 grown in 1/20 TSB 
(negative control) and (d) with 50 μ g/ml of FITC-labeled lectin domain of Cmpg5300.05_29. Holes in biofilms 
are indicated with arrows.
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E. coli UTI89, P. aeruginosa PA14, S. Typhimurium ATCC14028, S. aureus Rosenbach and SH1000 were 
grown routinely in LB medium with aeration at 37 °C. C. albicans SC5314 and S. cerevisiae BY4741 were grown 
in yeast-extract peptone dextrose (YPD) medium (2% peptone, 1% yeast extract, 2% glucose) under aerobic 
conditions at 37 °C.
Identification of cmpg5300.05_29 and Southern hybridization. The genome mining of CMPG5300 
and its alignment with L. plantarum WCFS1 in our previous study11 led to the identification of cmpg5300.05_29 
as a potential lectin-encoding gene of CMPG5300. This gene occurred on contig 54 and is potentially 
plasmid-encoded. To obtain the complete gene sequence, the gaps were closed by using the primers mentioned in 
Table S1. Furthermore, as the contig 54 containing the cmpg5300.05_29 gene sequence did not align with the msa 
gene of L. plantarum WCFS1 (lp_1229), efforts were made to identify whether the gene was present on the chro-
mosomal DNA or plasmid DNA. For this purpose, Southern hybridization41 was performed using the genomic 
DNA and plasmid DNA isolated from CMPG5300 (Malik et al.24). The primers used for constructing the probes 
are listed in supplementary information Table S1.
Construction of cmpg5300.05_29 knock-out mutant. In order to study the role of Cmpg5300.05_29, 
its gene was knocked out using double homologous recombination using a cre-lox strategy42 as described 
previously for the sortase gene srtA in L. plantarum CMPG530024. The corresponding plasmids and primers 
used are mentioned in Table 2 and Table S1, respectively. The mutant, CMPG11201, was selected on the basis 
of resistance against chloramphenicol and checked by PCR and Southern hybridization. For complementa-
tion, cmpg5300.05_29 was amplified using the primers PRO 8367 and PRO 8368 and ligated downstream of 
the dlt promoter in the vector pCMPG10208 resulting in pCMPG11202. CMPG11201 was complemented with 
cmpg5300.05_29 by electroporation of pCMPG11202 resulting in strain CMPG11202. To validate gene comple-
mentation, qRT-PCR was performed as done for CMPG5376 (Malik et al.24) using primers mentioned in Table S1.
Heterologous expression and purification of lectin domain of Cmpg5300.05_29. The recombi-
nant E. coli (BL21/DE3) (Table 2) expressing the lectin domains of Cmpg5300.05_29 (plasmid pCMPG11209) 
and Msa of L. plantarum WCFS1 (pCMPG11210) were grown overnight in LB with 50 μ g/ml kanamycin. Each 
culture was diluted 100-fold in 2 liter LB with kanamycin and grown for 2 to 3 h at 37 °C under agitation until 
Name of the species Name of the strain Relevant genotype/description Reference/source
Bacterial/yeast strains
L. plantarum
CMPG5300 Wild type, human vaginal isolate Malik et al.24
CMPG11201 Δcmpg5300.05_29::Cmr This study
CMPG11202 CMPG11201 complemented with cmpg5300.05_29 This study
WCFS1 Sequenced wild-type strain; single colony isolate of NCIMB 8826 from human saliva 48
E. coli
TOP10F F’ (lacIq, Tnr) mcrA_(mrr hsdRMS-mcrBC) 80LacZ_lacX74 deoR recA1 araD139_(araleu) Invitrogen
BL21/DE3 E. coli B F– dcm ompT hsdS(rB− mB−) gal λ (DE3) Invitrogen
UTI89 Wild type, clinical isolate 49
P. aeruginosa PA14 Wild type, human isolate 50
S. cerevisiae BY 4741 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0 51
C. albicans SC5314 (ATCC MYA-2876) Wild type, human clinical isolate 52
S. aureus
SH1000 rsbU positive derivative of S. aureus 8325-4 53
Rosenbach (ATCC 33591) Wild type, clinical isolate ATCC
S. enterica serovar 
Typhimurium
ATCC 14028 Wild type, isolated from chicken tissue ATCC54
ATCC 14028 carrying 
pFPV25.1 Mutant constitutively expressing GFP 46
Host Relevant description Reference/source
Plasmids
pNZ5319 E. coli pNZ5318 derivative for multiple gene replacements in gram-positive bacteria Cmr Eryr Lambert et al.
42
pCMPG10208 E. coli pLAB1301 derivative driven by dlt promoter, Apr, Eryr Unpublished results
pCMPG11201 E. coli pNZ5319 derivative containing homologous regions up- and downstream of cmpg5300.05_29, Cmr Eryr This study
pCMPG11202 E. coli pCMPG10208 derivative containing cmpg5300.05_29 of CMPG5300, Apr, Eryr This study
pET28 a+ E. coli Kanr, T7 lac, N and C-terminal His Tag Novagen
pCMPG11209 E. coli pET28a+ derivative containing the lectin domain of cmpg5300.05_29 of CMPG5300, Kanr This study
pCMPG11210 E. coli pET28a+ derivative containing the lectin domain of msa gene of L. plantarum WCFS1, Kanr This study
Table 2.  Strains and plasmids used in this study.
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an optical density (OD) (595 nm) between 0.3 and 0.4 was reached. Then the production of recombinant lec-
tin domain was induced with 1 mM isopropyl β -D-1-thiogalactopyranoside (IPTG) (Sigma-Aldrich). The next 
day, the pellets were suspended in 20 ml of non-denaturing lysis buffer (Sodium dihydrogen phosphate 50 mM, 
Sodium chloride 300 mM, Imidazole 10 mM, pH 8) per liter of original culture and incubated for 30 min at room 
temperature (RT) with gentle swirling. Subsequently the cell lysate was sonicated during 4 min in cycles of 30 sec 
on and 30 sec off (amplitude 18%) to release the soluble recombinant lectin domain from the cells. Subsequently, 
affinity chromatography was used to purify the lectin domains. Hereto, the lysate was first filtered with 0.2 μ M 
filters and the filtered lysate was run through a HisTrapTM HP column (GE Healthcare). Different fractions were 
collected and sample purity was analyzed through sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). The lectin domains were further purified from the eluted sample using size exclusion chromatog-
raphy, using a HighloadTM 16/60 column packed with a matrix of SuperdexTM prep grade (GE Healthcare). 
Fractions containing the purified lectin domains were collected, analyzed using SDS-PAGE and Western Blotting 
(with primary mouse monoclonal anti-His6 antibodies), pooled together and concentrated.
In vitro adhesion and biofilm formation. To assess the role of Cmpg5300.05_29 in adhesion of the strain 
to the vaginal epithelial cell line VK2/E6E7 and in biofilm formation on polystyrene, CMPG5300 and its mutant 
derivatives were analyzed using the adhesion and biofilm assays described previously (Malik et al.24).
Briefly the adherence of L. plantarum CMPG5300 strains to the epithelial cells was examined by adding 
1.5 ml of DMEM containing 107 CFU/ml. After incubation at 37 °C for 1 h, epithelial cells were washed twice with 
pre-warmed PBS. Subsequently, 100 μ l of trypsin-EDTA (1x) (Invitrogen) was added to each well and incubated 
for 10 min at 37 °C. Finally, 900 μ l of PBS was added, mixed and serial dilutions were plated out on MRS plates. 
Alternatively, a fluorescence assay was performed as described previously19 with minor modifications. The FITC 
labelled lectin domain of Cmpg5300.05_29 was suspended in the DMEM medium in the absence of serum and 
antibiotics, and incubated for 1 h with the monolayers of VK2/E6E7 cells grown on 13-mm coverslips. After incu-
bation, the cells were washed three times with PBS, and fixed with 4% paraformaldehyde for 10 min. Slides were 
examined with a Zeiss Axio Imager Z1 microscope using an EC Plan Neofluar (X40 magnification/0.3 numerical 
aperture) objective (excitation 488 nm, emission 511 nm). Pictures were acquired with an AxioCam MRm and 
the AxioVision.
Mannose-dependent S. cerevisiae and C. albicans agglutination assay. A yeast agglutination assay 
was performed using the protocol described previously (Pretzer et al.12) but with minor modifications. Briefly, 
overnight-grown cultures of Lactobacillus strains were washed, suspended in phosphate buffered saline (PBS, pH 
7.2) to a final concentration of 1 × 1010 CFUs/ml. Similarly, overnight cultures of S. cerevisiae or C. albicans cells 
were washed and suspended in PBS so as to a make a 1% w/v cell suspension. For agglutination, 25 μ l of bacte-
rial suspension was added to 25 μ l of PBS followed by 50 μ l of yeast cells suspension in a 96-well U-bottom well 
sterile plate (Greiner bio-one). The mixtures were incubated for 10 min at RT with gentle shaking. To study inhi-
bition, 25 μ l of methyl-α -D-mannopyranoside (50 mM; Sigma-Aldrich) was added to the bacterial suspension 
instead of PBS. To examine agglutination, the mixtures were spotted on a slide and viewed under a phase-contrast 
microscope (400-fold magnification, Zeiss Axio Imager Z1 microscope equipped with an AxioCam MRm Rev.3 
monochrome digital camera). Alternatively C. albicans and S. cerevisiae were incubated with 200 μ g/ml of fluo-
rescein isothiocyanate (FITC)-labeled lectin domain of Cmpg5300.05_29 alone and in combination with 25 μ l 
of methyl-α -D-mannopyranoside (50 mM; Sigma-Aldrich). As a control, a lectin L-type domain of lectin-like 
protein 2 (Llp2) from L. rhamnosus GG was used.
ELISA-based assay for assessing sugar binding. For a quantitative analysis of mannan binding, an 
ELISA-based assay (Velez et al.43) was used with minor modifications. The microtiter (X50 Immulon 4HBX 96 
well plates, Fischer Scientific) plate was coated with 10 μ g mannan from S. cerevisiae (Sigma Aldrich NV) or 
Bovine Serum Albumin (BSA) (Sigma Aldrich NV) (negative control) per well prepared in carbonate-bicarbonate 
buffer (pH 9.6) and incubated overnight at 4 °C. Overnight cultures of Lactobacillus strains were washed twice 
with PBS and suspended in 0.1 M carbonate buffer (pH 8.2) up to a final concentration of 1 × 1010 CFUs/ml. For 
labeling the cells, biotin N-hydroxysuccinimide ester (Sigma) was added to the cells at a concentration of 100 μ 
g/ml and the cells were incubated at RT for 1 h with gentle swirling. Subsequently, the wells were washed with 
distilled water and blocked with blocking buffer (TBSt20 with 0.5% blocking agent) for 2 h at RT. Simultaneously, 
the biotin-labelled cells were washed thrice with PBS and suspended in PBS so as to make a working concentra-
tion of 2.5 × 109 CFUs/ml. The cells were added to the pre-coated wells which were then washed with PBS and 
incubated for 1 h at 37 °C. Subsequently, the plate was washed with PBST (PBS with 0.025% Tween 20) to remove 
unbound cells. Color was developed by adding Alkaline Phosphatase (AP)-Strep (1:5000 in blocking buffer) in 
each well for 1 h at 37 °C. The plate was washed and 4-nitrophenyl phosphate (NPP) disodium salt (Sigma; 1 mg/
ml in carbonate bicarbonate buffer) was added as the substrate. Color was allowed to develop for 15–30 min at RT 
and the absorbance was read at 405 nm. The experiments were performed at least three times with six technical 
repeats each.
Pull-down sugar binding assays using Sepharose beads. Sepharose® 6B beads (Sigma-Aldrich) 
were coated with 20% D-glucose, GlcNac, D-mannose, D-fucose and mannan of S. cerevisiae, as previously 
described44,45 with minor modifications. For the sugar-binding assay, 25 μ l of each set of coated functionalized 
beads was washed with binding buffer as previously described45. 1 ml of binding buffer containing 50 μ g of the 
purified lectin domain of Cmpg5300.05_29 was added to each set of beads. Hereafter, the mixtures were incu-
bated for 2 h at 4 °C. The beads were washed twice with 1 ml of wash buffer and bound samples of lectin domain 
were eluted by boiling the beads in SDS-PAGE loading buffer (Fermentas, Life Sciences) for 10 min at 95 °C. 
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The eluates were resolved by SDS-PAGE through 12% polyacrylamide gels (Life Sciences), which were stained 
with Sypro® Ruby protein gel stain (Invitrogen) and scanned using the Typhoon scanner (GE Healthcare Life 
Sciences).
Glycan array analysis. To test a larger number of glycosylated substrates, the purified lectin domain was 
subsequently sent for glycan array screening at the Consortium for Functional Glycomics (CFG). The mamma-
lian glycan array version 5.2 was used to determine the exact sugar specificity of the lectin domain. The array 
consists of 609 glycan targets of natural and synthetic mammalian glycans with amino linkers and is printed 
onto N-hydroxysuccinimide (NHS)-activated glass microscope slides (SCHOTT Nexterion), forming cova-
lent amide linkages. The purified sample (lectin domain of Cmpg5300.05_29) was labeled with FITC by using 
FluoReporter® FITC Protein Labeling Kit (Life Technologies) according to the producer’s manual. Two differ-
ent concentrations of FITC labeled protein, namely 20 μ g/ml and 200 μ g/ml, were used to determine the exact 
sugar-binding capacity. The experiment was then performed by the Consortium for Functional Glycomics 
(CFG, www.functionalglycomics.org).
HIV-1 gp120 and gp41 binding assay via ELISA and SPR analysis. To determine the role of 
Cmpg5300.05_29 in binding to HIV-1 envelope glycoprotein gp120 and gp41, the cells of L. plantarum 
CMPG5300 and msl mutant strain CMPG11201 were labeled with biotin, incubated with 2 μ g/ml immobilized 
HIV-1 gp120 or gp41 (ImmunoDiagnostics Inc., Woburn, MA) (produced by CHO cell cultures) and assessed for 
binding using the ELISA-based method described above for mannan.
Furthermore, binding of the lectin domain was assessed by SPR analysis using the method described pre-
viously (Balzarini et al.16). Briefly, recombinant gp120 protein from HIV-1 strain IIIB and recombinant gp41 
protein from HIV-1 (HXB2 strain) (Acris Antibodies GmbH, Herford, Germany) (produced by Pichia pastoris) 
were covalently immobilized on the carboxymethylated dextran matrix of a CM4 sensor chip in 10 mM sodium 
acetate, pH 5.0, using standard amine coupling chemistry at final densities of 115 RUs and 45 RUs, respectively. 
In another set of experiments, binding of the lectin domain to gp120 and gp41 was subjected to a detailed kinetic 
characterization. A 1:1 fit was applied to obtain the association rate constant (ka), the dissociation rate constant 
(kd), and the apparent kinetic rate constant (KD). All interaction studies were performed at 25 °C on a Biacore 
T200 instrument (GE Healthcare, Uppsala, Sweden) in HBS-P (10 mM HEPES, 150 mM NaCl and 0.05% sur-
factant P20; pH 7.4) containing10 mM CaCl2. The CM4 sensor chip surface was regenerated with a single injec-
tion of 50 mM NaOH.
HIV-1 inhibition assays. The inhibitory activity of purified lectin domain against HIV-1(IIIB)- and HIV-
2-induced cytopathicity in C8166 and Raji DCSIGN cell cultures was examined in microtiter 96-well plates con-
taining ~3 × 105 cells/ml infected with 100 CCID50 of HIV per ml and appropriate dilutions of the test samples. 
After 4–5 days of incubation at 37 °C, C8166-induced giant (syncytium) cell formation was examined microscop-
ically and the 50% effective concentrations (EC50) determined.
Antimicrobial assays for interference with pathogen grown in suspension. In order to verify 
whether the lectin domain of Cmpg5300.05_29 affects the growth of pathogens, bioscreen experiments were 
performed. Overnight cultures of S. aureus SH1000, S. aureus Rosenbach, E. coli UTI89, and S. Typhimurium 
ATCC14028 were diluted 200-fold in Tryptic Soy Broth (TSB) medium and 200 μ l of cell suspensions were added 
to sterile wells of 100-well microtiter plates (Honeycomb, Oy Growth Curves Ab Ltd). The purified lectin domain 
of Cmpg5300.05_29 was added at concentrations of 50 μ g/ml and 200 μ g/ml. These were incubated at 37 °C for 3 
days under continuous agitation in a Bioscreen (Oy Growth Curves Ab Ltd), which measured the OD at 600 nm 
every 10 min to monitor growth. TSB was used as blank. Each strain and concentration of the sample containing 
lectin domain was tested in triplicate.
Antimicrobial assays for interference with pathogen growth in biofilms. The static peg biofilm 
assays were performed as described previously with minor modifications46,47. Hereto, E. coli UTI89, P. aeruginosa 
PA14, S. aureus SH1000, S. aureus Rosenbach and S. Typhimurium ATCC14028 were grown in the presence of 50 
or 200 μ g/ml of lectin domain of Cmpg5300.05_29. After 48 h of incubation, biofilm formation was quantified by 
coloring with crystal violet (0.1% w/v in 5% methanol, 5% isopropanol and 90% PBS). For each strain and con-
centration tested, the experiment was performed at least three times with eight technical repeats. Alternatively, 
the lectin domain of Cmpg5300.05_29 was added after 1.5 h (the initial adhesion phase of the tested pathogens). 
In a third version of the assay, the sample was added with fresh medium after 24 h to investigate if the lectin 
domain could disrupt an already established biofilm.
For the visualization of E. coli UTI89 and S. Typhimurium biofilms the FITC- labeled lectin domain of 
Cmpg5300.05_29 was added at the onset of the biofilm formation (t = 0 h) at 50 μ g/ml concentration and the 
biofilms were grown for 48 h. Microscopic epifluorescent imaging was performed using a Zeiss Axio Imager Z1 
microscope with an EC Plan Neofluar (X40 magnification/0.3 numerical aperture) objective (excitation 488 nm, 
emission 511 nm). Pictures were acquired with an AxioCam MRm and the AxioVision software.
Statistical analysis. To determine significant differences the unequal variance t-test was applied. A P-value 
below 0.05 was considered as statistically significant.
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